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Hepatic Cavernous Hemangioma in
Cirrhotic Liver: Imaging Findings
Objective: To document the imaging findings of hepatic cavernous heman-
gioma detected in cirrhotic liver.
Materials and Methods: The imaging findings of 14 hepatic cavernous heman-
giomas in ten patients with liver cirrhosis were retrospectively analyzed. A diag-
nosis of hepatic cavernous hemangioma was based on the findings of two or
more of the following imaging studies: MR, including contrast-enhanced dynamic
imaging (n = 10), dynamic CT (n = 4), hepatic arteriography (n = 9), and US (n =
10).
Results: The mean size of the 14 hepatic hemangiomas was 0.9 (range, 0.5
1.5) cm in the longest dimension. In 11 of these (79%), contrast-enhanced
dynamic CT and MR imaging showed rapid contrast enhancement of the entire
lesion during the early phase, and hepatic arteriography revealed globular
enhancement and rapid filling-in. On contrast-enhanced MR images, three
lesions (21%) showed partial enhancement until the 5-min delayed phases. US
indicated that while three slowly enhancing lesions were homogeneously hypere-
choic, 9 (82%) of 11 showing rapid enhancement were not delineated.
Conclusion: The majority of hepatic cavernous hemangiomas detected in cir-
rhotic liver are small in size, and in many, hepatic arteriography and/or contrast-
enhanced dynamic CT and MR imaging demonstrates rapid enhancement. US,
however, fails to distinguish a lesion of this kind from its cirrhotic background.
avernous hemangioma is the most common benign hepatic tumor.
Various imaging techniques all show that the condition usually presents
with fairly distinctive findings, but there can also be signs of a lesion with
atypical findings that must be distinguished from one that is malignant (1 6). Most he-
mangiomas do not change in size or appearance during follow-up studies (7 9), though
some investigators have suggested that cavernous hemangiomas degenerate and be-
come smaller or vanish during the process of liver cirrhosis (9 11). To our knowledge,
no report has described the imaging findings in cavernous hemangiomas detected in
cirrhotic liver. Because of the difficulty of distinguishing between hepatocellular carci-
nomas and hepatic cavernous hemangiomas in this circumstance, a description of the
imaging findings of hepatic cavernous hemangioma during the changes occurring in
liver cirrhosis is needed. In this report, we describe the imaging findings of hepatic cav-
ernous hemangiomas obtained during various imaging studies of cirrhotic liver.
MATERIALS AND METHODS
A search of dictation records at our institution, including those relating to CT and
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CMR imaging, revealed that during the five-year period
1995 1999, 822 cases of liver cirrhosis had been recorded.
In addition, the available hard copies of various imaging
studies disclosed 21 cases of hepatic cavernous heman-
gioma in 15 cirrhotic livers. In the process of case selection,
five patients with seven hemangiomas were excluded be-
cause only one imaging finding was available, with no ad-
ditional evidence from further radiologic investigation or
histologic proof. The remaining ten patients, in whom 14
cavernous hemangiomas were diagnosed as a result of two
or more imaging procedures, were included in this study. 
The lesions depicted on heavily T2-weighted static MR
images (n = 10) showed bright high signal intensities, as
well as contrast-enhancement on delayed contrast-en-
hanced images. On contrast-enhanced dynamic CT (n = 4)
or MR imaging (n = 10), peripherally discontinuous nodu-
lar enhancement on early-phase images, with progressive
and persistent enhancement on delayed images, was con-
sidered diagnostic. On angiograms (n = 9), a pooling of
contrast media within a lesion that had a characteristic ‘cot-
ton wool’ appearance, together with the retention of  con-
trast media well beyond the venous phase, was considered
a typical finding. Because of the variety of findings, as well
as the limitation of lesion-to-lesion correlation in each case,
US (n = 10) was not regarded as a confirmative study.
Seven of the ten patients were male and three were fe-
male, and their age ranged from 45 to 72 (mean, 57.5)
years. Liver cirrhosis was diagnosed pathologically (n = 2)
or on the basis of a patient’s laboratory data and radiologic
findings. The causes of cirrhosis were chronic B-viral he-
patitis (n = 6), chronic C-viral hepatitis (n = 1), alcoholic
cirrhosis (n = 2), or primary biliary cirrhosis (n = 1). At the
time that hemangiomas were detected, four patients also
had hepatocellular carcinoma.
Ten patients underwent MR imaging on a 1.5-T imager
(Magnetom Vision; Siemens, Erlangen, Germany) including
a T1-weighted spoiled gradient-echo sequence (TR [msec]
TE [msec], 113 161/4.1 for single-echo sequence or
140/2.7 and 5.3 for double-echo sequence) and a T2-
weighted turbo spin-echo sequence (TR range/effective TE,
3540 4060/138; echo train length, 29) for pre-contrast
imaging. For these same patients, gadolinium-enhanced
multiphase dynamic imaging (including the arterial,
parenchymal and 5-min delayed equilibrium phase) em-
ployed a T1-weighted spoiled gradient-echo sequence with
the same imaging parameters as in unenhanced imaging.
Four patients underwent unenhanced and contrast-en-
hanced two-phase (arterial and parenchymal or delayed)
dynamic CT scanning (HiSpeed Advantage; General
Electric Medical Systems, Milwaukee, WI). US, for all ten,
involved the use of an Acuson 128 scanner (Acuson,
Mountain View, CA) or an HDI-3000 scanner (Advanced
Technology Laboratories, Bothell, WA) fitted with a 3.5-
MHz convex or 5-MHz linear transducer, or both. 
For the nine patients who underwent hepatic arteriogra-
phy, a Multistar T.O.P (Siemens, Erlangen, Germany) ca-
pable of digital subtraction angiography was used.
All images were reviewed retrospectively by three expe-
rienced abdominal radiologists, and a consensus was
reached: size, speed of enhancement (percent enhance-
ment during the portal or parenchymal phase of dynamic
CT or MR imaging), the enhancement pattern seen during
hepatic arteriography, and echogenicity during sonography
were the factors considered. For lesion-to-lesion analysis
and in order to investigate the imaging findings of heman-
gioma detected in cirrhotic liver, all images for each pa-
tient, obtained during various imaging studies, were direct-
ly compared. 
RESULTS
The mean size of the 14 hepatic cavernous hemangiomas
was 0.9 (range, 0.5 1.5) cm in the longest dimension, mea-
sured on T2-weighted MR images in which all lesions
showed very bright signal intensity (Fig. 1). Nine (64%) of
14 lesions showed low signal intensity on T1-weighted MR
images (Fig. 1), but five could not be distinguished from
surrounding liver parenchyma. 
In 11 (79%) of the 14 lesions, contrast-enhanced dynam-
ic CT (n = 4) or MR imaging (n = 10) showed rapid con-
trast enhancement of the entire lesion during the arterial
and/or parenchymal phase and prolonged enhancement
during the delayed phase (Fig. 1). In four (36%) of these
11, perilesional parenchymal enhancement was noted dur-
ing the arterial phase (Fig. 2). Three others (21%) en-
hanced slowly, and until the 5-min delayed phase showed
partial enhancement (Fig. 3). 
During hepatic arteriography, 11 (85%) of 13 heman-
giomas, distributed among nine patients, showed punctate
or nodular contrast accumulation during the arterial phase
and complete filling-in during the capillary phase (Figs. 1,
2). Two (18%) of the 11 showed early contrast-filling of
perilesional small portal vein branches during the capillary
phase (Fig. 2). Two hemangiomas that enhanced slowly
during dynamic MR imaging were not delineated on hepat-
ic arteriograms.
Regarding the detection rate of US, and the echogenicity
demonstrated, only five lesions (36%) were distinguished
from surrounding hepatic parenchyma, either with (n = 2)
or without (n = 3) knowledge of the presence of the le-
sions. Three were homogeneously hyperechoic, and two
were hypoechoic (Fig. 1). The three sonographically hyper-
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Fig. 1. A 62-year-old woman with hypoechoic, rapidly enhancing small heman-
gioma detected in a cirrhotic liver caused by chronic B-viral hepatitis.
A. US depicts a 0.8-cm hypoechoic tumor (arrowheads) in the left lobe of the liver.
B. T2-weighted turbo spin-echo MR image (TR/TE, 4060/138) shows a tumor (ar-
row) with bright signal intensity. Another high signal intensity tumor is seen (arrow-
head), and this is a simple cyst.
C. Unenhanced T1-weighted spoiled gradient-echo MR image with fat suppression
(160.8/4.1) shows a low signal intensity tumor (arrow).
D. Arterial dominant phase spoiled gradient-echo image (160.8/4.1) reveals strong
enhancement of the tumor (arrow) seen in E.
E. Delayed phase spoiled gradient-echo image (160.8/4.1) obtained 5 min after the
start of contrast injection demonstrates persistent contrast enhancement of the tu-
mor (arrow). Simple cyst (arrowhead) is not enhanced after contrast injection.
F. Arterial phase of hepatic arteriography shows small C-shaped contrast puddling
(arrowheads).
G. Capillary phase of hepatic arteriography depicts more diffuse contrast accumu-
lation in the lesion (arrowheads) seen in F.
EF
Gechoic lesions corresponded with the slowly enhancing le-
sions depicted by dynamic MR imaging (Fig. 3), while the
two hypoechoic lesions showed rapid enhancement during
dynamic imaging (Fig. 1). US failed to demonstrate the re-
maining nine rapidly enhancing lesions.
DISCUSSION
According to a previous report (12), rapidly enhancing
hemangiomas tend to be hypoechoic at US, and it may be
difficult to distinguish a small hypoechoic lesion from the
coarse background of cirrhotic liver. Transient peritumoral
enhancement or the early appearance of small portal vein
branches adjacent to the lesion during contrast-enhanced
dynamic studies has also been described as a characteristic
finding of high-flow hemangiomas (13). Such findings sug-
gest that a transtumoral arterioportal shunt is no longer a
unique feature of hepatocellular carcinomas.
Regarding the small sizes of cavernous hemangiomas de-
tected in cirrhotic liver, it may be that a larger heman-
gioma has been reduced in size during the process of cir-
rhotic change. In a report describing the long-term follow-
up of hepatic hemangioma in patients with chronic liver
disease (11), one lesion accompanied by chronic hepatitis
regressed spontaneously after 48 months. It was suggested
that changes in blood flow, and in the intrahepatic environ-
ment as a result of hepatic fibrosis, may influence the re-
gression of a hemangioma.
Despite a lack of pathologic proof (3), some investigators
have suggested that central fibrotic degeneration, or hem-
orrhage and thrombosis, might cause decreased echogenici-
ty (7, 9). Central hemorrhage and thrombosis, however,
have been observed in larger hemangiomas, particularly gi-
ant ones, and should not enhance until the delayed phase
of contrast-enhanced studies. For small hemangiomas, de-
creased echogenicity can not be explained by central
thrombosis. Increased echogenicity of surrounding liver
parenchyma resulting from diffuse fatty infiltration or fi-
brotic change would make intrahepatic lesions relatively
hypoechoic (14). An actual decrease of echogenicity during
the direct compression of liver parenchyma (15) also sug-
gests another mechanism of decreased echogenicity of a
hemangioma detected in cirrhotic liver. The surrounding fi-
brotic changes occurring during cirrhosis would compress
the hemangioma, and the collapsed cavernous pool might
reduce the echogenic interfaces. 
One CT report with pathologic correlation (16) suggested
that hemangiomas with smaller vascular spaces would en-
hance more rapidly during dynamic CT than those with
larger vascular spaces. With regard to the high speed of
contrast enhancement of cavernous hemangiomas detected
in cirrhotic liver, a compressed cavernous pool and the re-
sultant small vascular spaces would be a cause of rapid en-
hancement in patients involved in the present study.
However, a cavernous hemangioma is composed of innu-
merable cavernous pools, and the arterial perfusional pres-
sure that determines the speed of blood flow in each vascu-
lar pool is different. Under such circumstances, the narrow-
ing of vascular pools caused by fibrotic distortion would
not be even. In other words, vascular pools with low perfu-
sional pressure would be compressed more easily than
those in which pressure is higher. Chronically compressed
vascular pools would be obliterated and intermingled with
hepatic fibrosis, but those that were hyperdynamic would
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Fig. 2. A 45-year-old man with small rapidly enhancing hemangioma in a cirrhotic liver resulting from chronic B-viral hepatitis.
A. Arterial dominant phase contrast-enhanced spoiled gradient-echo MR image (140/2.7) shows strong enhancement of a 0.9-cm tumor
(arrow) with wedge-shaped temporal peritumoral enhancement (arrowheads). On unenhanced T1-and T2-weighted, and delayed con-
trast-enhanced MR images (not shown), the area of wedge-shaped enhancement could not be distinguished from surrounding hepatic
parenchyma.
B. Capillary phase of hepatic arteriography shows near complete filling-in of the tumor by contrast agent (arrow), with opacification of a
small, proximal portal vein branch (arrowheads), suggesting a transtumoral shunt or drainage of the hyperdynamic tumor by this branch. 
ABremain in the cirrhotic liver. The increase in arterial blood
and perfusional pressure required to compensate for de-
creased portal perfusion in cirrhotic liver would partially
contribute to the hyperdynamic status of a cavernous he-
mangioma (17). These speculations should be verified by
future research that pathologic correlation.
This study suffers from several limitations. Case selec-
tion, for example, depended solely on imaging findings,
without pathologic confirmation. On the basis of a state-
ment made by Nelson and Chezmar (18), two or more
confirmatory study results were combined and used as a
diagnostic gold standard for each lesion. With regard to the
US findings which were entirely subjective, the hard copies
concerned, with retrospective review, were not useful for
lesion-to-lesion analysis in this study. During follow-up
however, when it was known that hemangiomas were pre-
sent, the majority of small ones could not be delineated
from the coarse background of cirrhotic liver. Finally, long-
term follow-up data for cirrhotic change was not available
for the majority of patients, and in no case was cirrhosis-re-
lated change in a hepatic cavernous hemangioma clearly
demonstrated.
In spite of these limitations, the results of this study sug-
gest that the majority of hepatic cavernous hemangiomas
detected in cirrhotic liver are small, and many enhance
rapidly at hepatic arteriography and contrast-enhanced dy-
namic CT or MR imaging. On US, these lesions can not be
readily distinguished from a cirrhotic background. In cir-
rhotic liver, hepatic cavernous hemangiomas are inciden-
tally discovered on dynamic CT or MR imaging during dai-
ly practice, and their hyperdynamic nature can be charac-
terized by hepatic arteriography.
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